The Challenges of COVID-19 with Obesity-Related Cancers
This reprint emphasizes the perspectives and challenges surrounding COVID-19 and obesity-related cancers, including but not limited to the risk factors of severe COVID-19 in cancer patients; the complications of COVID-19 in cancer patients; the challenges in cancer treatment and surgery; guidelines...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_100087 | ||
| 005 | 20230511 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230511s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7350-2 | ||
| 020 | |a 9783036573519 | ||
| 020 | |a 9783036573502 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7350-2 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Dalamaga, Maria |4 edt | |
| 700 | 1 | |a Nasiri-Ansari, Narjes |4 edt | |
| 700 | 1 | |a Spyrou, Nikolaos |4 edt | |
| 700 | 1 | |a Dalamaga, Maria |4 oth | |
| 700 | 1 | |a Nasiri-Ansari, Narjes |4 oth | |
| 700 | 1 | |a Spyrou, Nikolaos |4 oth | |
| 245 | 1 | 0 | |a The Challenges of COVID-19 with Obesity-Related Cancers |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (224 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This reprint emphasizes the perspectives and challenges surrounding COVID-19 and obesity-related cancers, including but not limited to the risk factors of severe COVID-19 in cancer patients; the complications of COVID-19 in cancer patients; the challenges in cancer treatment and surgery; guidelines for cancer care during COVID-19; delayed diagnosis and suboptimal cancer management; the impact of COVID-19 on cancer screening, early diagnosis and cancer presentation; immune response after SARS-CoV-2 infection and vaccination in cancer patients; psychological distress among cancer survivors; telehealth in cancer care; the role of diet and nutraceuticals in the prevention of severe COVID-19 and cancer; and the effects of COVID-19 pandemic on cancer research. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a COVID-19 | ||
| 653 | |a neutropenia | ||
| 653 | |a G-CSF treatment | ||
| 653 | |a respiratory failure | ||
| 653 | |a colorectal neoplasms | ||
| 653 | |a gastrointestinal neoplasms | ||
| 653 | |a immune checkpoint inhibitors | ||
| 653 | |a neoplasms | ||
| 653 | |a oncogenic viruses | ||
| 653 | |a oncolytic virotherapy | ||
| 653 | |a post-acute COVID-19 syndrome | ||
| 653 | |a reactive oxygen species | ||
| 653 | |a tumor escape | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a thyroid cancer | ||
| 653 | |a differentiated thyroid cancer | ||
| 653 | |a COVID-19 severity | ||
| 653 | |a inflammation | ||
| 653 | |a immunity | ||
| 653 | |a oxidative stress | ||
| 653 | |a obesity | ||
| 653 | |a SARS-Cov-2 | ||
| 653 | |a oncology | ||
| 653 | |a cancer screening | ||
| 653 | |a clinical trials | ||
| 653 | |a melanoma | ||
| 653 | |a management | ||
| 653 | |a pandemic | ||
| 653 | |a teledermatology | ||
| 653 | |a diagnostic delay | ||
| 653 | |a immunotherapy | ||
| 653 | |a vaccination | ||
| 653 | |a lymph adenopathy | ||
| 653 | |a cancer | ||
| 653 | |a nutraceuticals | ||
| 653 | |a supplements | ||
| 653 | |a colorectal | ||
| 653 | |a meta-analysis | ||
| 653 | |a gynecologic oncology | ||
| 653 | |a malignancy | ||
| 653 | |a blood cancer | ||
| 653 | |a hematologic malignancy | ||
| 653 | |a leukemia | ||
| 653 | |a lymphoma | ||
| 653 | |a multiple myeloma | ||
| 653 | |a myelodysplasia | ||
| 653 | |a breast cancer | ||
| 653 | |a cancer care | ||
| 653 | |a screening | ||
| 653 | |a surgery | ||
| 653 | |a psychological distress | ||
| 653 | |a cancer therapies | ||
| 653 | |a immunogenicity | ||
| 653 | |a safety | ||
| 653 | |a vaccine hesitancy | ||
| 653 | |a tumor subtype | ||
| 653 | |a mortality | ||
| 653 | |a intensive care unit | ||
| 653 | |a medico-administrative data | ||
| 653 | |a France | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7180 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100087 |7 0 |z DOAB: description of the publication |